Primary immunodeficiency diseases in adulthood

Internal Medicine Journal

Volumn 34, Issue 6, 2004, Pages 348-354

  Riminton, D S ^a,b   Limaye, S ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b Prim Immunodeficiency Dis Comm   (Australia)

Author keywords

Antibody; Genes; Hypogammaglobulinaemia; Immunodeficiency; Infection

Indexed keywords

COMPLEMENT; GAMMA INTERFERON;

ADULTHOOD; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ATAXIA TELANGIECTASIA; C1 INHIBITOR DEFICIENCY; CHRONIC GRANULOMATOUS DISEASE; CHRONIC MUCOCUTANEOUS CANDIDIASIS; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; GOOD SYNDROME; HUMAN; HYPERIMMUNOGLOBULIN E SYNDROME; HYPERIMMUNOGLOBULINEMIA M; ICOS DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOLOGY; INFECTION; LEUKOCYTE ADHESION DEFICIENCY TYPE 1; MBL DEFICIENCY; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; TYPE 1 CYTOKINE DEFICIENCY; X LINKED AGAMMAGLOBULINEMIA; X LINKED LYMPHOPROLIFERATIVE DISEASE;

ADULT; ANTIBODY FORMATION; CHILD; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MANNOSE-BINDING LECTIN;

EID: 3242768360     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00599.x     Document Type: Review

References (31)

1. Durandy A. Terminal defects of B lymphocyte differentiation. Curr Opin Allergy Clin Immunol 2001; 1: 519-24.
2. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-31.
3. International Union of Immunological Societies. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 1999; 118: 1-28.
4. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-68.
5. Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000; 97: 203-10.
6. Pan Q, Hammarstrom L. 2000 Molecular basis of IgG subclass deficiency. Immunol Rev 2000; 178: 99-110.
7. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003; 56: 12-6.
8. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86-99.
9. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-9.
10. Ozsahin H, Arredondo-Vega FX, Santisteban I, Fuhrer H, Tuchschmid P, Jochum W et al. Adenosine deaminase deficiency in adults. Blood 1997; 89: 2849-55.
11. Frucht DMM, Gadina GJ, Jagadeesh I, Aksentijevich K, Takada JJ, Bleesing J et al. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun 2001; 2: 422-32.
12. Morra M, Silander O, Calpe S, Choi M, Oettgen H, Myers L et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001; 98: 1321-5.
13. Grimbacher BSM, Holland JI, Gallin F, Greenberg SC, Hill HL, Malech JA et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999; 340: 692-702.
14. Anderson DC, Schmalsteig FC, Finegold MJ, Hughes BJ, Rothlein R, Miller LJ et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152: 668-89.
15. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Ong H et al. Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med 2001; 29: 728-36.
16. Chusid MJ, Parrillo JE, Fauci AS. Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobactenum fortuitum. JAMA 1975; 233: 1295-6.
17. Concannon P. ATM heterozygosity and cancer risk. Nat Genet 2002; 32: 89-90.
18. Zuccarello D, Salpietro DC, Gangemi S, Toscano V, Merlino MV, Briuglia S et al. Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis. J Med Genet 2002; 39: 671-5.
19. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
20. Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001; 1: 503-11.
21. Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000; 51: 111-22.
22. Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997; 100: 415-23.
23. Aittoniemi J, Koskinen S, Laippala P, Laine S, Miettinen A. The significance of IgG subclasses and mannan-binding lectin (MBL) for susceptibility to infection in apparently healthy adults with IgA deficiency. Clin Exp Immunol 1999; 116: 505-8.
24. Australian Health Ministers' Advisory Council. Review of the Use and Supply of Intravenous Immunoglobulins in Australia. Melbourne: Blood and Blood Products Committee; 2000.
25. Kronborg G, Garred P. Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet 2002; 360: 1176.
26. Arrendondo-Vega FX, Santisteban I, Notarangelo LD, El Dahr J, Buckley R, Roifman C et al. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delg, and E337del. Mutations in brief no. 142. Hum Mutat 1998; 11: 482.
27. Lammas DA, Casanova JL, Kumararatne DS. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol 2000; 121: 417-25.
28. Roy S, Hill AV, Knox K, Griffiths D, Crook D. Research pointers: Association of common genetic variant with susceptibility to invasive pneumococcal disease. BMJ 2002; 324: 1369.
29. Agnese DM, Galvano JE, Hahm SJ, Coyle SM, Corbett SA, Galvano SE et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186: 1522-5.
30. Stassen NA, Leslie-Norfleet LA, Robertson AM, Eichenberger MR, Polk HC Jr. Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery 2002; 132: 289-92.
31. Hurme M, Haanpaa M, Nurmikko T, Wang XY, Virta M, Pessi T et al. IL-10 gene polymorphism and herpesvirus infections. J Med Virol 2003; 70: S48-50.